Detalhe da pesquisa
1.
AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving Analysis.
Oncologist
; 25(12): e1990-e1995, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32721059